BioScrip, Inc. (BIOS) Misses Q1 EPS by 4c; Guides Above for FY

BioScrip, Inc. (NASDAQ: BIOS) reported Q1 EPS of ($0.05), $0.04 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $155.6 million versus the consensus estimate of $143.44 million.

BioScrip, Inc. sees FY2012 revenue of $600-$620 million, versus the consensus of $586.34 million.

For earnings history and earnings-related data on BioScrip, Inc. (BIOS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)
• Securitize Corp (SECZ) PT Lowered to $10 at Benchmark as Stock Plummets Post Q2 Earnings